期刊文献+

喜树碱微粉的制备工艺、溶出及生物利用度特征研究

Preparation,dissolution,and bioavailability characteristics of camptothecin micronized powder
原文传递
导出
摘要 目的对难溶性药物喜树碱(camptothecin)进行微粉化研究。方法借助乳化机和高压均质机采用乳化法制备喜树碱微粉,单因素法优化制备工艺。将最优乳化条件下得到的喜树碱微粉(camptothecin micronized powder)进行溶出和生物利用度研究。结果最佳制备工艺条件为聚山梨酯-80用量为0.4%,喜树碱在三氯甲烷-甲醇(8∶2)混合溶剂中的质量浓度为1 mg/m L,水相和油相体积比为7∶3,匀浆速率为7 000 r/min;匀浆时间为11 min。最佳工艺条件下得到的喜树碱微粉水中复溶后的粒径为(165.6±5.3)nm。扫描电镜结果显示喜树碱微粉呈现规则的长条状,颗粒大小比较均匀。溶出研究结果表明喜树碱微粉溶解度和溶出速率比原粉分别提高了1.36倍和4.09倍。口服生物利用度结果表明,与原料药相比,微粉化的喜树碱在大鼠体内的相对生物利用度提高了2.10倍。GC检测结果表明,喜树碱微粉溶剂残留符合ICH标准。结论乳化法制备喜树碱微粉后,改善了喜树碱原粉的溶解度和溶出速率,口服生物利用度得到提高。 Objective Camptothecin(CPT) as a kind of poorly soluble drug was conducted micronization research. Methods CPT micronized powder was prepared by emulsification method using emulsification machine and high pressure homogenizer. Moreover, single factor method was utilized to optimize. Dissolution and oral bioavailability study on CPT micronized powder prepared under the best emulsification conditions was conducted. Results The best preparation conditions were as follows: The dosage of Tween-80 as the surfactant was 0.4%; The concentration of CPT in chloroform-methanol(8∶2) mixed solution was 1 mg/m L; The volume ratio of water-organic phase was 7∶3; The homogenate speed was 7 000 r/min for 11 min. The particle size of CPT micronized powder prepared under the optimized conditions was(165.6 ± 5.3) nm. The scanning electron microscopy(SEM) results showed that CPT micronized powder presented regular strip shape and uniform particle size. The dissolution study indicated that the solubility and dissolution rate of CPT micronized powder was increased by 1.36 and 4.09 times compared with the raw CPT powder. The results of oral bioavailability showed that compared with the raw CPT powder, the relative bioavailability of CPT micronized powder in mice was increased by 2.10 times. The results of gas chromatography showed that residual solvents in CPT micronized powder accorded with the standard of ICH. Conclusion Solubility and dissolution rate of CPT are both improved since CPT micronized powder is prepared by emulsification method. So the oral bioavailability is also improved.
出处 《中草药》 CAS CSCD 北大核心 2016年第17期3016-3022,共7页 Chinese Traditional and Herbal Drugs
基金 "十二五"国家科技支撑项目(2012BAD21B05) 中央高校基本科研业务费专项(2752014AB10) 国家自然科学基金项目(21473023)
关键词 喜树碱 微粉化 生物利用度 乳化法 粒径 溶解度 camptothecin micronization bioavailability emulsification particle size solubility
  • 相关文献

参考文献18

  • 1江华,蒋朱明,蔡威,陶晔璇,王秀荣.脂肪乳[J].中国临床营养杂志,2007,15(1):17-20. 被引量:10
  • 2刘丹,张龙,达飞,尚沛津,张娟,姚琳.新型喜树碱类抗癌药物的研究进展[J].现代生物医学进展,2016,16(5):990-992. 被引量:9
  • 3谭慧心.拓扑异构酶Ⅰ抑制剂研究进展[J].中国药理学通报,2009,25(4):436-441. 被引量:13
  • 4江石湖,谭继宏,涂水平,蒋晓华,乔敏敏,章永平,吴云林,吴裕■.药物诱导胃癌细胞凋亡的初步探索[J].胃肠病学,1998,3(4):204-207. 被引量:4
  • 5Lian X H, Dong J X, Zhang J J, et al. Soluplus~ based 9-nitrocamptothecin solid dispersion for peroral administration: Preparation, characterization, in vitro and in vivo evaluation [J]. Int JPharm, 2014, 477(1/2): 399-407.
  • 6Waterhouse D N, Sutherland B W, Dos Santos N, et al. Irinophore C (TM), a lipid nanoparticle formulation ofirinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities [J]. lnvest New Drug, 2014, 32(6): 1071-1082.
  • 7Morise M, Niho S, Umemura S, et al. Low-dose irinotecan as a second-line chemotherapy for recurrent small cell lung cancer [J]. Jpn J Clin Oncol, 2014, 44(9): 846-851.
  • 8Bhattacharya S, Ray R M, Johnson L R. Cyclin- dependent kinases regulate apoptosis of intestinal epithelial cells [J]. Apoptosis, 2014, 19(3): 451-466.
  • 9任贵兵,毛中鹏,王磊,张府桓,孟小茹.喜树碱负载外泌体抗结肠癌作用[J].中华实用诊断与治疗杂志,2016,30(3):231-234. 被引量:8
  • 10Shirazi A N, Tiwari R K, Oh D, et al. Cyclic peptide-selenium nanoparticles as drug transporters [J]. MolPharm, 2014, 11(10): 3631-3641.

二级参考文献164

共引文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部